According to @StockMarketNews, Eli Lilly (LLY) shares are down more than 5% today, signaling heightened volatility in the biotech sector. This significant drop is drawing attention from traders monitoring pharmaceutical equities and their correlation with broader market sentiment. As large-cap stocks like Eli Lilly experience sharp declines, risk-off trends could extend to the crypto market, with investors potentially reallocating funds to safer assets. Traders should observe LLY’s price action for signals that may influence short-term crypto volatility, especially as biotech stocks often act as a sentiment barometer for risk appetite. Source: @StockMarketNews.